Business Today
Subscribe
NRICareer & JobsUS NewsInvestors CornerIn PicsWeatherFuel PricesPMS TodayBT Reels
BT Most Powerful WomenBT GolfEY Business Today Hidden Gems 2026
Search
Advertisement
Business News
markets
stocks
Symbiotec Pharmalab Ltd
Symbiotec Pharmalab Ltd

Symbiotec Pharmalab Ltd (SYMBIOTEC) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 2,97,702
Oct 22, 2026
  • NSE
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹1,197.50
₹-10.90 (-0.90%)
1,168.10Low
Today’s Performance
1,218.20High
934.20Low
52 Week’s Performance
1,309.90High

Stock Analysis

Stock Performance

  • 1 Day-0.90%
  • 1 Week-4.57%
  • 1 Month6.83%
  • 3 Months9.09%
  • 6 Months-%
  • 1 Year-%
  • 3 Years-%
  • 5 Years-%

Stock Summary

  • Face Value (₹)2.00
  • Beta0.52
  • 52-Week Low (₹)934.20
  • 52-Week High (₹)1,309.90
  • Price-to-Book (X)*5.92
  • Dividend Yield (%)-
  • Price-to-Earnings (P/E) (X)*70.06
  • Earnings Per Share (₹)17.10
  • Market Cap (₹ Cr.)*7,694.67
* Values as of last close price

COMPETITORS

BT TV

Cybersecurity Alert: AI Finds PHP Flaws, eMudhra Faces Certificate Concerns6:27Cybersecurity Alert: AI Finds PHP Flaws, eMudhra Faces Certificate Concerns
BrahMos CEO Exclusive | How BrahMos Is Expanding Production To Supply Vietnam, Indonesia & Russia11:12BrahMos CEO Exclusive | How BrahMos Is Expanding Production To Supply Vietnam, Indonesia & Russia
Global Cyber Scare: PHP Flaws Threaten Websites, eMudhra Lapse Sparks Security Alarm6:28Global Cyber Scare: PHP Flaws Threaten Websites, eMudhra Lapse Sparks Security Alarm
Budget FY28 | Centre Weighs Up to 20% Higher Fertiliser Subsidy: Sources2:31Budget FY28 | Centre Weighs Up To 20% Higher Fertiliser Subsidy: Sources
Market Commentary LIVE | Nifty - Sensex Today | Aditya Agarwal On What Investors Should Do Now13:16Market Commentary | Nifty - Sensex Today | Aditya Agarwal On What Investors Should Do Now
ETFs And BeES Explained: How To Invest And What Investors Should Know25:40ETFs And BeES Explained: How To Invest And What Investors Should Know
HFCL Q2 Results: Net Profit Jumps Over Fivefold To ₹363 Crore, Revenue More Than Doubles17:56HFCL Q2 Results: Net Profit Jumps Over Fivefold To ₹363 Crore, Revenue More Than Doubles
LIVE What’s Hot: Stocks, Gold & Big Money Moves | Daily Markets Show | October 22 | Business Today18:59What’s Hot: Stocks, Gold & Big Money Moves | Daily Markets Show | October 22 | Business Today
LIVE Daily Calls: Ask Your STOCK MARKET TODAY QUERIES | Market Update LIVE | Share Market News Today24:26Daily Calls: Ask Your STOCK MARKET TODAY QUERIES | Market Update | Share Market News Today
Pharma Stocks Outlook: Analyst Reveals His Top Pharma Picks After The Selloff1:49Pharma Stocks Outlook: Analyst Reveals His Top Pharma Picks After The Selloff
View more

FAQs

What was Symbiotec Pharmalab Ltd share price previously?
Symbiotec Pharmalab Ltd share price was down by -0.90% from the previous closing price of ₹1,208.40.
Who are peers of Symbiotec Pharmalab Ltd?
The peers of Symbiotec Pharmalab Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Torrent Pharmaceuticals Ltd, Zydus Lifesciences Ltd, Laurus Labs Ltd.
Who is/are the promoter/promoters of Symbiotec Pharmalab Ltd?
The promotor/promotors of Symbiotec Pharmalab Ltd are ANIL KUMAR SATWANI, Sunita Kishnani, PRATIK PATEL, Pramod Kasat, ROHIT BRIJMOHAN MANTRI, Dhananjay N Mungale, Salil Jain.
What has been 52-week high of Symbiotec Pharmalab Ltd stocks?
The highest price of Symbiotec Pharmalab Ltd stock is ₹1,309.90 in the last 52-week.
What is the share price of Symbiotec Pharmalab Ltd (SYMBIOTEC) today on NSE?
As on Oct 22, 2026 Symbiotec Pharmalab Ltd (SYMBIOTEC)’s share price on NSE is Rs 1197.5
What is the market cap of Symbiotec Pharmalab Ltd (SYMBIOTEC)?
The current market capitalisation of Symbiotec Pharmalab Ltd (SYMBIOTEC) is 7,694.67 crores
What is Symbiotec Pharmalab Ltd Share symbol?
The symbol of Symbiotec Pharmalab Ltd is SYMBIOTEC.
What is the PE ratio of Symbiotec Pharmalab Ltd (SYMBIOTEC)?
The current PE ratio of Symbiotec Pharmalab Ltd (SYMBIOTEC) is 70.06.
What is the PB ratio of Symbiotec Pharmalab Ltd (SYMBIOTEC)?
The current PB ratio of Symbiotec Pharmalab Ltd (SYMBIOTEC) is 5.92.
Today’s High & Low share prices of Symbiotec Pharmalab Ltd (SYMBIOTEC) on NSE?
Today, the share price of Symbiotec Pharmalab Ltd (SYMBIOTEC) on NSE touched a high of Rs 1218.2 and a low of Rs 1168.1
What price did Symbiotec Pharmalab Ltd (SYMBIOTEC) shares open on the NSE today?
On NSE, the share price of Symbiotec Pharmalab Ltd (SYMBIOTEC) opened at Rs 1194.1
What is the 52-week high of Symbiotec Pharmalab Ltd (SYMBIOTEC)?
The 52-week high price of Symbiotec Pharmalab Ltd (SYMBIOTEC) is Rs 1,309.90
What is the 52-week low of Symbiotec Pharmalab Ltd (SYMBIOTEC)?
The 52-week low price of Symbiotec Pharmalab Ltd (SYMBIOTEC) is Rs 934.20

About Symbiotec Pharma

Symbiotec Pharmalab Ltd, incorporated in the year 2002, has its registered office in 385/2 Pigdamber Near, Mashal Hotel Rau, Indore, Madhya Pradesh, 453331, +91-731-6676405. The main industry in which Symbiotec Pharmalab Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln.

Auditor/Auditors for Symbiotec Pharmalab Ltd is/are SRBC & Co LLP. In the main management, ANIL KUMAR SATWANI is chairman and Salil Jain is the company secretary for Symbiotec Pharmalab Ltd.

  • AKS
    ANIL KUMAR SATWANIChairman / Executive Director / M D / Promoter
  • SK
    Sunita KishnaniIndependent Non Exe. Director
  • PP
    PRATIK PATELIndependent Non Exe. Director
  • PK
    Pramod KasatIndependent Non Exe. Director
  • RBM
    ROHIT BRIJMOHAN MANTRINominee
  • DNM
    Dhananjay N MungaleNominee
  • SJ
    Salil JainCompany Sec. & Compli. Officer

Top Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.